“Molecular Docking Study of Gingkgo Biloba Compounds As Potential Inhibitors of SARS-CoV-2”. 2022. SCRIPTA SCORE Scientific Medical Journal 4 (1): 30-43. https://doi.org/10.32734/scripta.v4i1.8399.